HirschmanSZ. Current therapeutic approaches to viral hepatitis. Clin Infect Dis1995; 20: 741–6.
2.
HadleyS. Diagnosis and treatment of hepatitis A, B, and C. Continuing education broadcast, Ohio State University Medical Networks, February 10, 1995.
3.
Licensure of inactivated hepatitis A vaccine and recommendation for use among international travelers. MMWR Morb Mortal Wkly Rep1995; 44 (29): 559–60.
4.
KrawsczynskiK. Hepatitis E. Hepatology1993; 17: 932–41.
5.
Protection against viral hepatitis: recommendations of the Immunization Practice Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep1990; 39 (RR-2): 1–26.
6.
AlterMJHadlerSCJudsonFNMaresAAlexanderMJHuPYRisk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C viras infection. JAMA1990; 264: 2231–5.
7.
LettauLA. The A, B, C, D and E of viral hepatitis: spelling out the risks for health care workers. Infect Control Hosp Epidemiol1992; 13: 77–81.
8.
PerrilloRPSchiffEDavisGBodenheimerHCJrLindsayKPayneJA randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med1990; 323: 295–301.
9.
DavisGL. Interferon treatment of chronic hepatitis C. Am J Med1994; 96 (suppl 1A): 41S–6S.